Advertisement: TTP Killer 50
8 July, 2013 - 12:27 By News Desk


Sentimag Endomag

Endomag is developing a clinical platform that uses safe magnetic fields to power diagnostic and therapeutic devices, avoiding the safety, workflow and availability concerns of ionising radiation. 

Without changing clinical procedures or outcomes, Endomag’s products put the surgeon in control and enhance the patient experience, saving time and money in hospitals across the world by improving workflow and efficiency.
Endomag was founded in 2007 as a spin-out from the University College London and the University of Houston. The company is currently selling products across Europe, the Middle East, Africa and Australasia and is seeking marketing authorisation in other countries to deliver its technology to global markets.


Newsletter Subscription

Stay informed of the latest news and features